{
  "ptid_time": "141_S_1378_2019-05-02",
  "img_path": "/data/qiuhui/data/adni/images/141_S_1378/2019-05-02/t1.nii.gz",
  "img_finding": "Image findings: ventricular volume measures 55,558 mm³, 97.9% above the reference mean. With a Z-score of 2.24 (98.8th percentile), this represents significant enlargement; hippocampal volume measures 5,716 mm³, 19.7% below the reference mean. With a Z-score of -1.80 (3.6th percentile), this represents moderate atrophy; whole brain volume measures 920,647 mm³, 5.5% below the reference mean. With a Z-score of -0.70 (24.3th percentile), this represents normal volume ; entorhinal cortex volume measures 3,733 mm³, 1.6% above the reference mean. With a Z-score of 0.10 (54.0th percentile), this represents normal volume ; fusiform gyrus volume measures 17,531 mm³, 3.0% above the reference mean. With a Z-score of 0.28 (60.9th percentile), this represents normal volume ; middle temporal gyrus volume measures 15,945 mm³, 16.8% below the reference mean. With a Z-score of -1.46 (7.2th percentile), this represents mild atrophy. ",
  "text_data": "Age is 73.8 years. Gender is Female. Education: 16 years. MMSE: 27.0. MoCA: 26.0. Logical Memory: 13.0. APOEε4 alleles: 1.0. Biomarker levels: Florbetapir (AV45): 1.44 SUVR (significant elevated). ",
  "true_diagnosis": "Diagnosis: MCI.",
  "gpt_diagnosis": "**Reasoning:** The imaging data shows significant ventricular enlargement (consistent with atrophy) and moderate hippocampal atrophy, both of which are strong biomarkers for Alzheimer's disease (AD). The preserved MMSE and MoCA scores suggest mild cognitive impairment (MCI) rather than full dementia, but the presence of amyloid pathology (AV45+) and APOE4 carrier status increase AD risk.  \n\n**Diagnosis:** **MCI (likely due to Alzheimer’s pathology)**  \n**Confidence:** **High**  \n\n*(Note: The preserved cognitive scores rule out dementia, but the structural and biomarker findings strongly suggest early AD-related MCI.)*",
  "timestamp": "2025-07-26T16:59:11.112026"
}